"We can foresee a share price recovery to $0.20 within the next 6-12 months."A stark contrast to Patterson's gloomy prognosis.Now for the climb back up the Matterhorn.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025